A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC)

In this largest-to-date, first prospectively enrolled, real-world Chinese OC cohort, olaparib demonstrated a well-tolerated and manageable safety profile (including in special populations) with appropriate management, regardless of treatment lines. No new safety signals were identified.

Authors

Institutions

Publication Details

Journal
Journal of Ovarian Research
Published
2025-12-17
DOI
https://doi.org/10.1186/s13048-025-01924-8
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC)

Weiwei Feng, Zhen Shen, Yingjie Yang, Yuanming Shen et al.
Journal of Ovarian Research
PARP inhibition in cancer therapy
article

A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC)

Weiwei Feng, Zhen Shen, Yingjie Yang, Yuanming Shen, Huaying Wang, Wenjun Cheng, Yue Wang, Xipeng Wang, Chunhua Tu, Li Sun, Qingshui Li, Ziling Liu, Lingling Xie, Congzhu Li, Qionghua Chen, Rutie Yin, Yi Zhang, Xiping Luo, Ge Lou, Zhang Ping, Jianwei Zhou, Fengxia Xue, Haiying Li, Hongying Yang, Hongwu Wen, Shan Kang, Dongyan Cao, Zhongqiu Lin, Bei Lin, Ruixia Guo, Yang Shen, X. Wu, Liguo Ma, Li Wang
article en

Abstract

In this largest-to-date, first prospectively enrolled, real-world Chinese OC cohort, olaparib demonstrated a well-tolerated and manageable safety profile (including in special populations) with appropriate management, regardless of treatment lines. No new safety signals were identified.

Journal of Ovarian ResearchVol. 19(1)
Hebei Medical University (CN), Nanchang University (CN), Guiyang Medical University (CN), Harbin Medical University (CN), Sun Yat-sen University (CN), Shanghai Jiao Tong University (CN), Jilin University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Sichuan University (CN), Kunming Medical University (CN), Peking Union Medical College Hospital (CN), XinHua Hospital (CN), Ruijin Hospital (CN), Tianjin Medical University General Hospital (CN), Southern University of Science and Technology (CN), Shantou University (CN), Soochow University (CN), First Affiliated Hospital of Xiamen University (CN), The Fourth People's Hospital (CN), Cancer Hospital of Shantou University Medical College (CN), Fudan University Shanghai Cancer Center (CN), Sun Yat-sen Memorial Hospital (CN), Shandong Tumor Hospital (CN), Guizhou Cancer Hospital (CN), Third Affiliated Hospital of Harbin Medical University (CN), Zhongda Hospital Southeast University (CN), Fourth Hospital of Hebei Medical University (CN), Zhangjiagang First People's Hospital (CN), First Hospital of Jilin University (CN), Peking University First Hospital (CN), Henan Provincial People's Hospital (CN), Quantum Design (Germany) (DE), Women's Hospital, School of Medicine, Zhejiang University (CN), First Hospital of China Medical University (CN), Southern Medical University Shenzhen Hospital (CN), Henan Cancer Hospital (CN), Guangdong Province Women and Children Hospital (CN), Obstetrics and Gynecology Hospital of Fudan University (CN), First Affiliated Hospital of Zhengzhou University (CN), Second Affiliated Hospital of Zhejiang University (CN), Shandong First Medical University (CN), First Affiliated Hospital of Nanchang University (CN), Shenzhen Second People's Hospital (CN), Nanjing Medical University (CN), China Medical University (CN)
Openalex Percentile: Top 44%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.